Cite
MLA Citation
Estela Pineda et al.. “Dynamic soluble changes in sVEGFR1, HGF, and VEGF promote chemotherapy and bevacizumab resistance: A prospective translational study in the BECOX (GEMCAD 09-01) trial.” Tumor biology, vol. 39, no. 6, 2017, p. . http://access.bl.uk/ark:/81055/vdc_100073032536.0x0000d8